Articles tagged "Outcome"

2022 American Transplant Congress
Textbook Outcome in Lung Transplantation: Planned VA ECMO versus Off-Pump
S. E. Halpern¹, M. C. Wright², G. Madsen², B. Chow², J. C. Haney³, J. A. Klapper³, B. A. Bottiger², M. G. Hartwig³
¹Duke University School of Medicine, Durham, NC, ²Anesthesiology, Duke University Medical Center, Durham, NC, ³Surgery, Duke University Medical Center, Durham, NC
*Purpose: Planned venoarterial extracorporeal membrane oxygenation (VA ECMO) is increasingly used during bilateral orthotopic lung transplantation (BOLT) and may be superior to off-pump (OP) support…
2022 American Transplant Congress
Outcomes of Primary Simultaneous Pancreas-Kidney Transplants by Induction Agent in the United States
A. Cerise¹, T. Shaker¹, K. Ramanathan¹, S. Jackson², R. Kandaswamy¹, S. Riad³
¹Surgery, University of Minnesota, Minneapolis, MN, ²Analytics, MHealth-Fairview, Minneapolis, MN, ³Medicine, University of Minnesota, Minneapolis, MN
*Purpose: Induction immunosuppression choice for simultaneous pancreas-kidney (SPK) transplants varies widely in the United States. We examined the association between induction agents and outcomes of…
2022 American Transplant Congress
Compliance with OPTN Infectious Disease Testing
L. Irwin
Massachusetts General Hospital, Boston, MA
*Purpose: Effective 3/1/21 OPTN policy requires all transplant recipients to have pre-transplant and post-transplant infectious disease testing performed at specific intervals: upon admission and prior…
2022 American Transplant Congress
Infections Requiring Hospitalization After Simultaneous Pancreas-Kidney Transplantation Compared to Kidney Transplantation Alone
J. Grasberger¹, F. Ortiz², A. Ekstrand², V. Sallinen¹, M. Lempinen¹, I. Helanterä¹
¹Transplantation and Liver Surgery, Helsinki University Hospital, Helsinki, Finland, ²Nephrology, Helsinki University Hospital, Helsinki, Finland
*Purpose: Although infections related to surgical complications are more common after simultaneous pancreas-kidney transplantation (SPK) compared to kidney transplantation alone (KTA), the burden of infections…
2022 American Transplant Congress
Early Experience with 4-drug Maintenance Immunosuppression in Kidney and Pancreas Transplant Recipients
S. Mouawad¹, C. Shoemaker², J. Geyston³, A. Nishio Lucar³
¹University of Virginia Health System, Charlottesville, VA, ²Pharmacy, UVA Health, Charlottesville, VA, ³University of Virginia, Charlottesville, VA
*Purpose: Belatacept based immunosuppression regimens in kidney transplant recipients have been associated with better kidney function, improved metabolic profile, less de novo DSA formation and…
2022 American Transplant Congress
Eliminating Hepatitis C Positive Status from Kidney Donor Profile Index (KDPI) Calculations Results in Improved Transplant Rates and Outcomes in an Elderly Veteran Population
R. Lopez-Soler¹, A. Thorndyke¹, C. Trotter¹, A. Abadier², M. Samra¹
¹Surgery, Transplantation, Edward Hines Jr. Veterans Administration Hospital, Hines, IL, ²Surgery, Loyola University Medical School, Maywood, IL
*Purpose: Overall mortality on the kidney transplant waiting list is higher for older patients. The average age of waitlisted veteran patients is 64, with patients…
2022 American Transplant Congress
Does the New Kidney Transplant Allocation System Impact Delayed Graft Function Rates After Kidney Transplantation?
P. N. Chotai¹, F. Siddiqui², A. Logan³, K. Washburn⁴, A. Schenk⁵, A. Limkemann³
¹Division of Transplantation, Department of General Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, ²Ohio State University, Bloomfield, NJ, ³The Ohio State University Wexner Medical Center, Columbus, OH, ⁴The Ohio State University, Columbus, OH, ⁵Ohio State University Wexner Medical Center, Bexley, OH
*Purpose: The Organ Procurement and Transplantation Network (OPTN) implemented a new, distance based, kidney transplant allocation system (nKAS) for recipients of deceased donor kidney transplant…
2022 American Transplant Congress
Sodium-Glucose Co-Transporter 2 Inhibitors; Short-Term Outcome in Diabetic Kidney Transplant Recipients
J. Yagan¹, T. S. Mahmoud¹, A. Hasan², O. Gheith¹, n. El-Serwy¹, S. Rida¹, M. Mostafa¹, M. Shaker¹, P. Nair¹, T. Alotaibi¹
¹Nephrology, Hamed Al-Essa Organ Transplant Center, Kuwait, Kuwait, ²Immunometabolism, Dasman Diabetes Center, Kuwait, Kuwait
*Purpose: The idea of using SGLT2i in kidney transplant recipients (KTR) is a legitimate one after the recent encouraging data for their use in other…
2022 American Transplant Congress
COVID-19 in Solid Organ Transplant: A Global Perspective
.. C19TxR Consortium
ESOT, NHSBT, UNOS, CareDx, South San Francisco, CA
*Purpose: Transplantation has been disrupted dramatically by COVID-19 due to reallocation of healthcare resources and concerns from early reports of increased mortality rates (20-30%) in…
2022 American Transplant Congress
HLA Alleles Add to Risk Stratification for CMV Infection in Renal Transplant Recipients
R. Patil¹, R. Prashar², M. Ramesh², A. Patel²
¹Wayne State University School of Medicine, Detroit, MI, ²Henry Ford Transplant Institute, Detroit, MI
*Purpose: Cytomegalovirus (CMV) is the most common viral infection that occurs after solid organ transplantation. The incidence of CMV infection or disease (I/d) varies based…